Diabetes, Digestive, and Kidney Diseases Extramural Research — CFDA 93.847

Extramural research at $17.3 billion

USAspending.gov records $17,283,124,047.25 in obligations under CFDA 93.847. Seven thousand six hundred thirty-two awards produce that stock. A simple average is about $2.26 million per award, in the same band as other large extramural research CFDAs. The assistance-listing title is DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH. Awards land here only if tagged 93.847.

The packet does not allocate the $17.3 billion across the three disease words in the title. Searchers who want only diabetes or only kidney awards will not find that split in these four facts. The program table may show award descriptions; this copy does not invent percentages.

USAspending.gov is the source for $17,283,124,047.25 in obligations on CFDA 93.847, along with 7,632 awards, 676 recipients, and 51 states. Institute-level nicknames that do not appear as 93.847 in the award file do not roll into this total. The title’s three disease areas share one CFDA number in this extract. The $17.3 billion is the combined obligation stock, not a published split and not cash already drawn.

Six hundred seventy-six recipients in 51 states

Six hundred seventy-six recipients share 7,632 awards, or about 11 award records per recipient on average. Splitting $17.3 billion evenly would assign about $25.6 million per recipient. Research universities and medical centers often hold many concurrent 93.847 awards; the extract reports the count, not a concentration curve.

Fifty-one states in the geographic count describe nationwide coding in the USAspending state field. It does not mean research dollars track diabetes prevalence by state. Place-of-performance follows coded recipient locations, which can cluster in research metros.

Extramural is not a clinic ledger

CFDA 93.847 sizes extramural research assistance tagged to this listing. It does not count dialysis sessions, transplants, or patients treated. Award count (7,632) is a count of assistance records, including supplements and renewals as stored. Citing 7,632 as studies completed would still be a stretch the packet does not support.

Cardiovascular, aging, and neuroscience research remain separate CFDAs. Adding them to 93.847 would invent a combined disease-research total this packet does not contain.

Obligations versus draws on 93.847 awards

The $17.3 billion is an obligation total from USAspending.gov. Outlays on extramural research usually trail as institutions draw over a project period. This page does not publish a spend-down. Closeout deobligations reduce the stock; competing renewals increase it.

When an institution’s ledger disagrees with USAspending, filter to CFDA 93.847 and to obligations rather than expenditures. Those two checks remove most false conflicts.

Opening the 93.847 table

The diabetes, digestive, and kidney extramural research program page overlays these aggregates. The all-programs index ranks 93.847 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other research listings. For 93.847 only, use the program page.

CFDA 93.847 stores $17,283,124,047.25 in obligations on 7,632 awards and 676 recipients, with a 51-state geographic count. Diabetes, digestive, and kidney research share one CFDA number; they do not share a published dollar split in these four facts. About $2.26 million per award and about 11 awards per recipient match other extramural research files. Seven thousand six hundred thirty-two is not a patient census. Fifty-one geographic labels do not track prevalence.

Dialysis counts, transplants, and laboratory outlays are outside the packet. Keep 93.847 on its own row. The program page overlays this listing. Source: USAspending.gov assistance awards.

Three disease words, one obligation stock

Diabetes, Digestive, and Kidney Diseases Extramural Research, CFDA 93.847, shows $17,283,124,047.25 in obligations, 7,632 awards, 676 recipients, and 51 states on USAspending.gov. The title names three disease areas; the four facts do not split the $17.3 billion among them. About $2.26 million per award and about 11 awards per recipient on simple averages match other large extramural research files. Searchers who want only diabetes or only kidney awards will not find that percentage in this packet.

Six hundred seventy-six recipients across 51 states is a nationwide institutional roster in the USAspending state field. It does not allocate dollars by diabetes prevalence. Place-of-performance follows coded recipient locations. Seven thousand six hundred thirty-two is a count of assistance records, including supplements and renewals as stored, not a count of patients treated.

Do not add other disease-research listings into the $17.3 billion. Do not treat the stock as outlays. The program page overlays 93.847; the programs index ranks it; agency pages may include this CFDA among other research listings. Source: USAspending.gov assistance awards.

Questions

How much is obligated for diabetes, digestive, and kidney research?

USAspending.gov records $17,283,124,047.25 in obligations for CFDA 93.847. SpendingVault indexes 7,632 awards, 676 recipients, and 51 states. The figure is an obligation sum from assistance awards, not an outlay. The packet does not split the total among the three disease areas in the title.

How many institutions receive CFDA 93.847 awards?

The extract lists 676 recipients against 7,632 awards, about 11 award records per recipient on a simple average. An even split of $17.3 billion would be about $25.6 million per recipient; actual portfolios are uneven. Names are on the program page.

Does 51 states mean funding follows diabetes prevalence?

No. Fifty-one states appear in the USAspending geographic count. That reports how many state labels are attached to 93.847 awards. It does not allocate dollars by disease prevalence. Place-of-performance often follows research institutions. CFDA 93.847’s $17.3 billion on 7,632 awards and 676 recipients is the USAspending obligation stock.

Is $17.3 billion already spent on this research?

Not necessarily. Obligations are commitments on assistance awards tagged 93.847. Outlays are payments as institutions draw. This page reports the obligation stock from USAspending.gov and does not publish cash-paid or remaining-balance figures. CFDA 93.847’s $17.3 billion on 7,632 awards and 676 recipients is the USAspending obligation stock.